Early Phase 1 Acute Myeloid Leukemia (AML) Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Multiple MyelomaLymphomaHematologic Malignancy+5 more

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8 enrolled1 locationNCT06398457

Recruiting

Early Phase 1

Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML)

Hrain Biotechnology Co., Ltd.7 enrolled1 locationNCT06760260

Recruiting

Early Phase 1

EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML)CAR-T

Zhimin Zhai9 enrolled1 locationNCT06642025